Portola Pharmaceuticals Inc  

(Public, NASDAQ:PTLA)   Watch this stock  
Find more results forPTLA
25.98
-0.38 (-1.44%)
Sep 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 25.45 - 26.79
52 week 19.59 - 31.48
Open 25.92
Vol / Avg. 0.00/269,530.00
Mkt cap 1,091.21M
P/E     -
Div/yield     -
EPS -2.67
Shares 41.40M
Beta     -
Inst. own 92%
Nov 3, 2014
Q3 2014 Portola Pharmaceuticals Inc Earnings Release (Estimated) - 4:00pm GMT-5 - Add to calendar
Sep 9, 2014
Portola Pharmaceuticals Inc at Morgan Stanley Healthcare Conference
Aug 6, 2014
Q2 2014 Portola Pharmaceuticals Inc Earnings Call - Webcast
Aug 6, 2014
Q2 2014 Portola Pharmaceuticals, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -1298.14% -791.49%
Operating margin -1304.56% -799.34%
EBITD margin - -785.68%
Return on average assets -40.94% -35.34%
Return on average equity -49.21% -159.12%
Employees 70 -
CDP Score - -

Address

270 E. Grand Avenue
SOUTH SAN FRANCISCO, CA 94080
United States - Map
+1-650-2467000 (Phone)
+1-650-2467376 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Portola Pharmaceuticals, Inc. (Portola) is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.

Officers and directors

Charles J. Homcy M.D. Co-Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Hollings C. Renton III Independent Co-Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
William Lis Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Mardi C. Dier Chief Financial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
John T. Curnutte M.D. Ph.D. Executive Vice President - Research & Development
Age: 61
Bio & Compensation  - Reuters
Peter Strumph Vice President - Technical and Clinical Operations
Bio & Compensation  - Reuters
John H. Johnson Director
Age: 56
Bio & Compensation  - Reuters
Jeffrey W. Bird M.D., Ph.D. Independent Director
Age: 53
Bio & Compensation  - Reuters
Robert C. Califf M.D. Independent Director
Age: 63
Bio & Compensation  - Reuters
Nicholas G. Galakatos Ph.D. Independent Director
Age: 56
Bio & Compensation  - Reuters